Cargando…
Risk of COVID-19 for patients with cancer
Autores principales: | Xia, Yang, Jin, Rui, Zhao, Jing, Li, Wen, Shen, Huahao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130057/ https://www.ncbi.nlm.nih.gov/pubmed/32142622 http://dx.doi.org/10.1016/S1470-2045(20)30150-9 |
Ejemplares similares
-
The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
por: Fan, Huahao, et al.
Publicado: (2022) -
Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution
por: Su, Jun-wei, et al.
Publicado: (2020) -
Risk of COVID-19 for patients with cancer
por: Wang, Hanping, et al.
Publicado: (2020) -
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
por: Zhao, Liang, et al.
Publicado: (2021) -
Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Zhang, Guosen, et al.
Publicado: (2020)